Wordt geladen...
Striving for optimal bronchodilation: focus on olodaterol
β(2)-agonists were introduced in the 1940s as bronchodilators to be used in obstructive respiratory diseases. Long-acting β(2)-agonists have been a mainstay of bronchodilating treatment for decades. Recently, agents extending their effect to 24 hours and thus allowing the once-daily administration w...
Bewaard in:
| Gepubliceerd in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780202/ https://ncbi.nlm.nih.gov/pubmed/27042036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S96070 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|